Tags

Type your tag names separated by a space and hit enter

Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
Trans Am Neurol Assoc. 1969; 94:85-90.TA

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Controlled Clinical Trial
Journal Article

Language

eng

PubMed ID

4907453

Citation

Schwab, R S., and A C. England. "Amantadine HCL (Symmetrel) and Its Relation to Levo-Dopa in the Treatment of Parkinson's Disease." Transactions of the American Neurological Association, vol. 94, 1969, pp. 85-90.
Schwab RS, England AC. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease. Trans Am Neurol Assoc. 1969;94:85-90.
Schwab, R. S., & England, A. C. (1969). Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease. Transactions of the American Neurological Association, 94, 85-90.
Schwab RS, England AC. Amantadine HCL (Symmetrel) and Its Relation to Levo-Dopa in the Treatment of Parkinson's Disease. Trans Am Neurol Assoc. 1969;94:85-90. PubMed PMID: 4907453.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease. AU - Schwab,R S, AU - England,A C,Jr PY - 1969/1/1/pubmed PY - 2001/3/28/medline PY - 1969/1/1/entrez SP - 85 EP - 90 JF - Transactions of the American Neurological Association JO - Trans Am Neurol Assoc VL - 94 SN - 0065-9479 UR - https://www.unboundmedicine.com/medline/citation/4907453/Amantadine_HCL__Symmetrel__and_its_relation_to_Levo_Dopa_in_the_treatment_of_Parkinson's_disease_ L2 - https://medlineplus.gov/parkinsonsdisease.html DB - PRIME DP - Unbound Medicine ER -